Bio-Techne Corporation Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 493.78 M

Bio-Techne Corporation Selling, General, and Administrative Expenses (SG&A) is USD 493.78 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 18.91% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • Bio-Techne Corporation Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 415.26 M, a 6.96% change year over year.
  • Bio-Techne Corporation Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 388.25 M, a 7.02% change year over year.
  • Bio-Techne Corporation Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 362.78 M, a 22.75% change year over year.
  • Bio-Techne Corporation Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 295.53 M, a 8.61% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue